Occasional Digest

Inovio wins case in dispute with VGXI, GeneOne Life Science (INO:NASDAQ)

Lawyer with a hammer put forward

bymuratdeniz/iStock via Getty Images

  • Inovio Pharmaceutical (INO) won an $80.4M judgment in a lawsuit that accused VGXI and GeneOne Life Sciences of violating a supply agreement.
  • Inovio argued that the two companies declined to abide by technology transfer obligations that would have allowed

Source link

Exit mobile version